It also prevents the body from releasing too much glucagon, a hormone that increases blood sugar levels
Understanding this timeline helps set realistic expectations and supports treatment adherence during the critical early months of therapy
Gut dysbiosis (an imbalance in the microbiome) has also been shown to lead to GLP-1 resistance, meaning your body doesnt properly respond to GLP-1 even when its released
Some large database analyses have suggested a modest increase in pancreatitis risk, particularly in the first few months after initiation, while others have found no association after adjusting for confounding factors such as obesity, gallbladder disease, and alcohol use
Their outcomes were compared by looking at their medical records and accounting for factors including age, sex, race, BMI, tobacco use, and other health issues
Retatrutide solo data